Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Multi Indocitra Tbk. (MICE)

Indofarma Tbk.Trading
Multi Indocitra Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofarma Tbk. dan Multi Indocitra Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Multi Indocitra Tbk. diperdagangkan di Rp540 (kapitalisasi pasar 336 M, volume 24 jam 8,4 rb). Perbedaan utamanya: Indofarma Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

INAFMICE
Kapitalisasi Pasar
390,51 M336 M
Volume
8,4 rb
Lot
84
Perputaran
4,58 jt
Harga Rata-rata
545,54
Nilai Transaksi
4,58 jt

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INAF
Lihat detail
MICE
Lihat detail

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF

Tentang Multi Indocitra Tbk.

PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.

Selengkapnya di halaman MICE